Picture of Anika Therapeutics logo

ANIK Anika Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Brief: Anika Therapeutics Q1 Loss Per Share $0.20

May 5 (Reuters) - Anika Therapeutics Inc  ANIK.O :
    * ANIKA REPORTS FIRST QUARTER FISCAL 2022 FINANCIAL RESULTS
    * Q1 ADJUSTED LOSS PER SHARE $0.11
    * Q1 LOSS PER SHARE $0.20
    * Q1 REVENUE ROSE 7 PERCENT TO $36.7 MILLION

Source text for Eikon:  ID:nGNXf7nPV 
Further company coverage:  ANIK.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Anika Therapeutics

See all news